SP Scientific to Supply lyophilizer with ControLyo Nucleation On-Demand Technology to AAIPharma

Published on January 10, 2014 at 6:55 AM · No Comments

SP Scientific, a leading provider of well-established and highly regarded scientific equipment brands, and AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical analytical testing, product development and manufacturing services, entered into a purchase agreement where SP will supply AAIPharma with a LyoStar 3 pilot-scale lyophilizer paired with a complementing Hull production-scale Lyophilizer, both equipped with Praxair’s ControLyo™ Nucleation On-Demand Technology.  

“By procuring both the pilot-scale and production scale lyophilizers with ControLyo™ technology, AAIPharma significantly enhances its lyophilization development and optimization capabilities while dramatically increasing our scalability and total lyophilization capacity,” stated James Fife, senior director of parenteral operations at AAIPharma.  “Cycles will be developed on site in the LyoStar 3 and easily transferred to the production-scale dryer.”

ControLyo™ Nucleation On-Demand Technology allows the manufacturer to control the nucleation temperature during freezing and ensure that all vials nucleate simultaneously. Numerous benefits have been demonstrated for controlled nucleation including improved vial-to-vial homogeneity, reduced primary drying times, improved cake appearance, reduction in vial breakage and better stability for many protein based formulations. William Downs, president and CEO of SP Industries commented as follows: “ControLyo™ technology is the most significant advancement in freeze drying in perhaps decades. It is rapidly being adopted by the industry and those that hesitate to utilize the technology run a real risk of being left behind in a competitive marketplace. We are pleased to see AAIPharma adopt the technology, and believe that as an early adopter they have created a compelling competitive advantage.”

The pilot-scale lyophilizer will be fully validated and operating within AAIPharma’s cGMP facility by February, 2014. The production scale lyophilizer is scheduled to come online in late 2014. 

Posted in: Business / Finance | Device / Technology News | Pharmaceutical News

Tags:

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post